EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online April 11, 2008
Experimental Biology and Medicine doi: 10.3181/0712-RM-333
© 2008 by the Society for Experimental Biology and Medicine

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
233/6/721    most recent
0712-RM-333v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L. F.
Right arrow Articles by Tanaka, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L. F.
Right arrow Articles by Tanaka, Y.


Regular Manuscript

Generation of mature dendritic cells with unique phenotype and function by in vitro short-term culture of human monocytes in the presence of interleukin-4 and interferon-{beta}

Li Feng Zhang 1, Kazu Okuma 1, Reiko Tanaka 1, Akira Kodama 1, Kayo Kondo 1, Aftab A. Ansari 2, and Yuetsu Tanaka 1*

1 University of the Ryukyus
2 Emory Univ Sch of Med

* To whom correspondence should be addressed. E-mail: yuetsu{at}s4.dion.ne.jp.


   Abstract

Dendritic cell (DC)-based immunotherapy has been utilized for the treatment of not only a number of human malignancies but also a select group of infectious diseases. Conventional techniques for the generation and maturation of DC require 7 days of in vitro culture, which prompted us to seek alternative methods that would hasten the generation of functional human myeloid DCs in vitro. Following the use of a number of cytokines/growth factors, we found that in vitro culture of purified human monocytes in media containing interleukin (IL)-4 together with interferon (IFN)-{beta} for 24 hrs followed by the addition of non-specific antigenic stimuli such as the use of keyhole limpet hemocyanin (KLH), lipopolysaccharide (LPS) or inactivated human immunodeficiency virus (HIV)-1 induced the monocytes to differentiated by 3 days into mature DCs (4B-DCs). These 4B-DCs expressed high levels of CD83 and CD11c as well as markers of immune activation including CD80 and CD86, HLA class I and II, and CD14 but not CD1a. Anti-CD14 blocking antibody interfered with generation of 4B-DCs only by LPS but not by KLH or HIV-1. Interestingly, 4B-DCs, but not conventional DCs generated using macrophage-colony stimulating factor (GM-CSF) and IL-4 (G4-DCs), expressed OX40 and OX40L. 4B-DCs showed phagocytic activity, and spontaneously produced IL-12 and tumor necrosis factor (TNF)-{alpha} but not IL-10. 4B-DCs promoted proliferation of allogeneic naïve CD4+ T cells producing IFN-{gamma} at lower levels than those stimulated with G4-DCs. 4B-DCs were more potent to stimulate allogeneic bulk CD8+ T cells producing IFN-{gamma} than G4-DCs. These data indicate that 4B-DCs are unique and may provide a relatively more rapid alternative tool for potential clinical use as compared with the use of conventional G4-DCs.

Key Words: dendritic cell, immune stimulation, type-I IFN, IL-4, OX40, human monocyte







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Experimental Biology and Medicine.